N R Jog1, R Caricchio. 1. Rheumatology Section, Department of Medicine, Temple Autoimmunity Center, Temple University School of Medicine, Philadelphia, PA, USA.
Abstract
Cell death can be divided into the anti-inflammatory process of apoptosis and the pro-inflammatory process of necrosis. Necrosis, as apoptosis, is a regulated form of cell death, and Poly-(ADP-Ribose) Polymerase-1 (PARP-1) and Receptor-Interacting Protein (RIP) 1/3 are major mediators. We previously showed that absence or inhibition of PARP-1 protects mice from nephritis, however only the male mice. We therefore hypothesized that there is an inherent difference in the cell death program between the sexes. We show here that in an immune-mediated nephritis model, female mice show increased apoptosis compared to male mice. Treatment of the male mice with estrogens induced apoptosis to levels similar to that in female mice and inhibited necrosis. Although PARP-1 was activated in both male and female mice, PARP-1 inhibition reduced necrosis only in the male mice. We also show that deletion of RIP-3 did not have a sex bias. We demonstrate here that male and female mice are prone to different types of cell death. Our data also suggest that estrogens and PARP-1 are two of the mediators of the sex-bias in cell death. We therefore propose that targeting cell death based on sex will lead to tailored and better treatments for each gender.
Cell death can be divided into the anti-inflammatory process of apoptosis and the pro-inflammatory process of necrosis. Necrosis, as apoptosis, is a regulated form of cell death, and Poly-(ADP-Ribose) Polymerase-1 (PARP-1) and Receptor-Interacting Protein (RIP) 1/3 are major mediators. We previously showed that absence or inhibition of PARP-1 protects mice from nephritis, however only the male mice. We therefore hypothesized that there is an inherent difference in the cell death program between the sexes. We show here that in an immune-mediated nephritis model, female mice show increased apoptosis compared to male mice. Treatment of the male mice with estrogens induced apoptosis to levels similar to that in female mice and inhibited necrosis. Although PARP-1 was activated in both male and female mice, PARP-1 inhibition reduced necrosis only in the male mice. We also show that deletion of RIP-3 did not have a sex bias. We demonstrate here that male and female mice are prone to different types of cell death. Our data also suggest that estrogens and PARP-1 are two of the mediators of the sex-bias in cell death. We therefore propose that targeting cell death based on sex will lead to tailored and better treatments for each gender.
Several studies have shown that the response of males and females to stress
differs.[1, 2, 3] It is generally believed that females respond to infection
and trauma with increased antibody production, which may also increase their risk of
developing autoimmune diseases.[1, 2, 3, 4]
Higher prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE),
Sjogren's syndrome and rheumatoid arthritis (RA) in females supports this
notion.[1, 5, 6] Interestingly, inflammation is usually considered more
severe in males resulting in an increased mortality.[3,
4, 7]Several inflammatory diseases show differences in severity and outcome between the two
sexes. Males have larger stroke areas and more severe sepsis. Acute respiratory distress
syndrome (ARDS) shows rapid destruction of lung tissue in males, and estrogens delay the
damage.[8, 9, 10] However, some autoimmune diseases such as ANCA-associated
vasculitis and IgA nephropathy also show higher incidence in males.[1, 11] Moreover, although SLE is more
prevalent in females, renal disease in SLE is often more severe in males and has a poor
prognosis.[12, 13,
14]Du et al.[15] reported innate gender
differences in response to cytotoxic agents and programmed cell death. XY neurons were more
susceptible to nitrosative stress and exhibited a proclivity towards an apoptosis-inducing
factor-dependent pathway, while XX neurons were more susceptible to apoptosis-inducing
agents and show a proclivity towards the cytochrome c-dependent pathway. The
authors showed that these gender-dependent differences were due to the incapacity of XY
neurons to maintain intracellular levels of reduced glutathione: a prominent defense against
oxidative stress. Li et al.[16] also
demonstrated an intrinsic female neuroprotection in hippocampus organotypic slice cultures
after oxygen and glucose deprivation, suggesting again a sexually dimorphic use of cell
death pathways.During physiological stress, the activated immune system secretes pro-inflammatory
cytokines in addition to the activation of NADPH oxidase and generation of reactive oxygen
species. This initial response leads to increased cell death, which further directs the
immune response. Several forms of cell death have been identified. Apoptosis, traditionally
considered a form of programmed cell death, is anti-inflammatory whereas necrosis and
necroptosis are pro-inflammatory.[17, 18, 19] Necrosis is also
accepted as a regulated form of cell death, and specific signaling pathways have been
identified. One such pathway is regulated by Poly-(ADP-Ribose) Polymerase-1
(PARP-1).[17, 18]
PARP-1 is a DNA repair enzyme whose enzymatic activity is induced by DNA
damage.[20] PARP-1 and the induction of necrosis
have been involved in several pathogenic processes, from stroke to rheumatoid
arthritis.[21] We showed previously that
increased oxidative stress and the resultant DNA damage lead to hyperactivation of PARP-1 in
the kidneys during immune-mediated nephritis.[22]
Inhibition or absence of PARP-1 results in reduced renal inflammation and better survival of
mice. Interestingly, protection conferred by absence or inhibition of PARP-1 showed a
sex-bias, with only male mice being protected.These results suggest that the differences in stress response in males and females may be
due to a difference in the cell death program in the two sexes. We therefore hypothesized
that males are prone to PARP-1necrosis, whereas females are prone to caspase-dependent
apoptosis.It has been reported that estrogens can enhance the resistance to oxidative
stress.[23] Furthermore, the sex-bias we
observed in the activity of PARP-1 may be partially explained by the ability of PARP-1 to
interact with estradiol and estrogen receptor α (ERα).
ERα complex stabilizes PARP-1 binding to DNA and diminishes the capacity of
PARP-1 to hyperactivate.[24] We showed previously
that treatment of male mice with 17β Estradiol (E2) conferred protection
against immune-mediated nephritis. Here we aimed at determining whether estrogens had a role
in defining the susceptibility of male and female cells to different forms of cell
death.
Results
PARP-1 is activated in both male and female mice during nephritis
We previously observed a sex bias in the activity of PARP-1. To determine whether this
bias was due to the activation of PARP-1 in only one sex, we determined PARP-1
activation in male and female mice during lupus nephritis. The comparison of kidney
disease between male and female mice is often challenging due to the sex-bias of disease
severity in various mouse models of lupus. We took advantage of the new model developed
by Dr. Davidson's group.[25] We used
kidneys from NZW/BXSB F1 male and female mice. The NZW/BXSB F1 male mice
spontaneously develop lupus, whereas the female mice develop similar disease severity
when injected with Interferon alpha (IFNα). The kidney sections from male
and female mice were stained for Poly (ADP-Ribose) Polymers (PARs) as a measure of
PARP-1 activation. In Figures 1a and b, we show that PARP-1
was activated in male and also in female mice that were injected with
IFNα.
Figure 1
PARP-1 is activated in both male and female mice during nephritis. (a) Kidney
sections from (NZWxBXSB)F1 mice were stained with DAPI to identify nuclei and with
anti-PARs to identify PARP-1 enzymatic activity; bottom panels shows secondary antibody
only. Female mice were injected with AdvIFNα at 8 weeks and were 22 weeks
old at the time of the staining. The male mice were 18 weeks old. The figures are
representative of six mice. (b) Fluorescence intensities of red channel were
measured using ImageJ software. Fluorescence intensities of the secondary controls were
subtracted from the stained sections. An average of 5–7 fields was calculated for
each mouse. Data are mean±S.E.M. *P<0.05,
**P<0.005. (c) NTN was induced in PARP-1+/+ or
PARP-1−/− mice by injecting NTS. Kidneys were collected 30 h and
3 days after induction of NTN and stained with anti-PAR, Fluoroscein-conjugated
anti-Complement C3 and DAPI. PARs were visualized by Rhodamine-conjugated secondary
antibody. The figure shows that although C3 deposition in PARP-1−/−
kidneys was same as PARP-1+/+ kidneys, PAR accumulation was absent in
PARP-1−/− kidneys. These data show that PARP-1 is responsible for the
majority of poly (ADP-ribosyl)-ation in the kidney during nephritis and therefore PARs
can be used as a measure of PARP-1 activity in the kidney
PARs are a product of poly (ADP-ribosyl)-ation, and several members of the PARP family
can mediate this reaction.[20] To further
demonstrate the role of PARP-1 we used nephrotoxic serum (NTS)-induced nephritis (NTN)
as a model of immune-mediated nephritis.[22] In
this model mice are injected with serum (NTS) from a sheep immunized with mouse
glomeruli. The NTN is characterized by initial heterologous phase where the injected
antibodies (NTS) bind glomerular antigens, fix complement and initiate an inflammatory
response. An advantage of the NTN model is that it allows to ‘bypass' the
upstream events during systemic autoimmunity that lead to loss of tolerance and
generation of auto-antibodies.[26, 27] Moreover, recent evidence suggests that, irrespective
of the upstream events leading to immune-mediated nephritis, the downstream mechanisms
involved in renal tissue damage are similar.[26,
27] NTN in PARP-1-deficient mice demonstrates
that PARP-1 is responsible for the majority of poly (ADP-ribosyl)-ation in the nephritic
kidney, and therefore PAR accumulation can be used as a measure of PARP-1 activation
(Figure 1c). Moreover the data obtained from this model
can be applied to other immune-mediated nephropathies including lupus nephritis.
Absence of PARP-1 activity rescues from necrotic cell death
Sex hormones are known to have an important role in the immune system. However,
evidence suggests that the genetic differences between males and females may also
contribute to the observed differences in phenotype between the two sexes.[28, 29] To determine the
differences in response to necrotic stimuli due to sex-chromosome component, we induced
cell death in bone marrow-derived macrophages (BMDM) from male and female mice. We used
BMDM because our previously published data with bone marrow chimera show that PARP-1
absence is required in both immune and non-immune compartments for protection against
immune-mediated nephritis.[22] The results
suggested that not only intrinsic renal cells but also bone marrow-derived hematopoietic
cells undergo PARP-1-dependent cell death during nephritis. Figure
2a shows that lower concentrations of hydrogen peroxide induced apoptosis,
whereas higher concentrations induced necrosis as determined by Annexin V and 7AAD
positivity. Figure 2a also shows that the dose required for
inducing cell death in male and female cells was the same, suggesting that male and
female cells do not differ in their susceptibility to H2O2-induced
apoptosis or necrosis. Intracellular active caspase-3 further confirmed that lower
concentrations of H2O2 induced apoptosis, whereas high doses
induced necrosis (Figure 2b). We also performed western
blots on whole-cell lysates from male and female BMDMs stimulated with increasing
concentrations of H2O2. Similar to our data with flow cytometry,
western blot analysis shows that caspase-3 is activated when BMDMs are stimulated with
lower concentrations, but not with higher concentrations
(500 μM) of H2O2 (Figure 2c). Late apoptotic cells may release active caspase-3 in
the culture supernatant as a result of the loss of membrane integrity. To demonstrate
that the percentage of late apoptotic cells in our system was negligible, we determined
the levels of active caspase-3 in the supernatants. We did not detect any active
caspase-3 released in the supernatants by dying cells (Figure
2d). We have confirmed by confocal microscopy that increasing doses of
H2O2 induce apoptosis and necrosis respectively (Figures 2e–g) and that under these circumstances the
Caspase-3 inhibitor only interferes with apoptosis (Figures 2h and
i). These data show that both male and female cells show similar
susceptibility to H2O2-induced cell death and higher
concentrations of H2O2 induces primary necrosis in both male and
female cells. Finally, Figure 2 also suggests that, as
described previously, necrotic cells can also be Annexin V-positive,[30, 31] however, caspase-3
activation is specific for apoptosis.
Figure 2
Male and female cells show similar susceptibility to H2O2-induced
cell death. BMDM from male and female 129s mice were stimulated with various
concentrations of H2O2 for 2 h. (a) The cells were
harvested and stained for FITC conjugated Annexin V and 7AAD, and acquired on FACS
Canto. One representative of two independent cultures is shown. (b) BMDMs were
stimulated, harvested, fixed, permeabilized and stained with PE-conjugated active
caspase-3 antibodies. Cells were acquired on a FACS Canto and analyzed using FlowJo. One
representative of four independent cultures is shown. (c) BMDMs were stimulated
with increasing concentrations of H2O2 as in (a). Cells
were lysed after 2 h stimulation. Western blot analysis shows that higher
concentration of H2O2-induced necrosis as seen by absence of
active caspase-3 in cell lysates (upper panel). Lower panel shows the ratios of band
density of active caspase-3 to β actin band density, which was used as a
loading control. (d) Active caspase-3 was not detected in concentrated culture
supernatants from BMDMs treated with H2O2. Upper panel:
concentrated supernatants from male BMDMs, lower panel: concentrated supernatants from
female BMDMs. ‘−' and ‘+' represent lysates of
untreated Jurkat cells (−) or Jurkat cells treated with camptothecin (+).
BMDMs from male and female were labeled with Hoechst 33342 and stimulated with
H2O2 for 2 h. Cells were fixed and imaged. Apoptotic and
necrotic cells were counted. (e) Representative examples of live, apoptotic and
necrotic cells are shown. Cells were identified as apoptotic or necrotic according to
Figure 2e. Stimulation with 500 μM
H2O2-induced necrosis in both male (f) and female BMDMs
(g). Caspase-3 inhibition by Z-DEVD-FMK did not inhibit necrosis induced by
500 μM H2O2 in either male (h) or
female (i) BMDMs. The data show that both male and female cells show similar
susceptibility to H2O2-induced cell death and higher
concentrations of H2O2 induce necrosis in both male and female
cells
To further determine whether necrosis induced by H2O2 is
PARP-1-dependent, male and female BMDMs from wild-type or PARP-1-deficient mice were
stimulated with H2O2. Figures
3a–d shows that while PARP-1deficiency inhibited necrosis in male
cells, H2O2-induced cell death in female macrophages was
independent of PARP-1 activation. These data are in agreement with our previous results.
PARP-1 deficiency in male cells not only inhibited necrosis but also induced apoptosis,
and did not change the viability. Pharmacological inhibition of PARP-1 also inhibited
necrosis and increased apoptosis in male cells (not shown). The data suggest that male
BMDM undergo a PARP-1-dependent cell death program. We also observed increased apoptosis
in the absence of PARP-1 in female cells. Although the reason is not clear yet and
requires further studies, a possibility is that in the absence of PARP-1 the DNA repair
machinery is ineffective and therefore the cells are facilitated to undergo apoptotic
cell death. However, as female cells do undergo necrosis, we sought to determine if the
necrosis in female cells was through a newly identified cell death program:
necroptosis.[19] Necroptosis is dependent on
Receptor-Interacting Protein Kinase 1 and 3 (RIP-1 and RIP-3). Necroptosis can be
inhibited by either a small-molecule inhibitor of RIP-1, Necrostatin-1,[32] or by genetic deletion of RIP-3. To determine whether
female cells preferentially undergo necroptosis, we stimulated BMDMs from
RIP-3-sufficient or RIP-3-deficient mice with H2O2. Figures 3e–h show that necrotic death induced by
H2O2 in both male and female cells is independent of RIP-3
activation. Inhibition of RIP-1 by Necrostatin-1 also did not alter cell death in male
or female cells (not shown). These data are in line with observations from Vanden Berghe
et al.[33] that
H2O2-induced cell death is independent of RIP-1/3
activation.
Figure 3
H2O2-induced necrosis is PARP-1 dependent in male BMDM. BMDM from
male and female 129s mice or 129 PARP-1−/− mice
(a–d); B6 or RIP-3−/− mice (e–h)
were stimulated with H2O2. The cells were collected and stained
for FITC conjugated Annexin V and Propidium Iodide/7AAD, and acquired on FACS Canto.
Data are mean±S.E.M., representative of two independent cultures is shown. The
data show that H2O2-induced cell death in male cells is dependent
on PARP-1 activation while necrosis in both males and females is independent of RIP-3
activation. *P<0.05, ***P<0.0005
Estradiol inhibits necrotic cell death
Mabley et al.[24] showed that PARP-1
interacts with ERα and estrogen, and due to this interaction, estrogen
may inhibit PARP-1 activity. Moreover, we also showed that estradiol treatment of male
mice conferred protection against immune-mediated nephritis, similar to PARP-1
inhibition. Therefore, to determine whether estrogens can also inhibit necrotic cell
death by inhibiting PARP-1 activity, we induced necrosis in male and female cells in the
presence or absence of 17β estradiol (E2). Figures 4a
and d show that E2 inhibited necrotic cell death in both male and female
cells. Although E2 treatment rescued female macrophages from both necrosis and
apoptosis, in males E2 only inhibited necrosis (Figures 4b and
e). We further determined the ability of estrogens to inhibit PARP-1 activity
in male and female BMDMs stimulated with H2O2. Figure 4g shows that E2 inhibited PARP-1 activity in male cells in a
dose-dependent manner. As expected, E2 treatment did not inhibit PARP-1 activity in
female BMDMs upon H2O2 treatment (Figure
4h). Instead PARP-1 inhibitor reduced PARP-1 activity in both male and female
BMDMs (not shown).
Figure 4
17β Estradiol influences PARP-1 activation and cell death in male and
female cells. (a–f) BMDM from male and female 129s mice were
pre-treated with various concentrations of E2 for 3 h followed by 2 hours
stimulation with H2O2. The cells were harvested and stained for
FITC-conjugated Annexin V and Propidium Iodide/7AAD. Results were acquired on FACS
Canto. The data show that E2 rescues female cells from death, whereas it shifts cell
death program to apoptosis in male cells. Data are mean±S.E.M.; representative of
four independent experiments is shown. (g and h) BMDMs were seeded in
96-well plates and pre-treated with E2 for 3 h. Following stimulation with
H2O2, PARP-1 activity in the cells was determined by a
colorimetric assay as described in Materials and Methods. The data show that E2 inhibits
PARP-1 activity in male (g) but not in female cells (h). Data are
mean±S.E.M. of triplicates. One representative of three experiments is shown.
(i and j) ERα mRNA levels were determined in BMDMs
treated with E2 and stimulated with H2O2 as in
(a–f) by quantitative real-time PCR. Relative mRNA level
calculated from a standard graph was normalized to mRNA levels in untreated cells. The
data show that E2 treatment does not alter ERα expression in male
(i) or female (j) cells. Data are mean±S.E.M., representative of
six mice. *P<0.05, **P<0.005
Estrogens mediate their effect through two receptors: Estrogen Receptor
α (ERα) and Estrogen Receptor β
(ERβ). The level of expression of estrogen receptors (ERs),
ERα and ERβ, is important because a preponderance of one
ER subtype over the other might change estrogen effects.[34] Hall and McDonnell[35]
showed that ERβ can modulate ERα transcriptional activity,
and thus the relative expression levels of the two isoforms may define the cellular
responses to agonists. E2 treatment is known to modulate ER expression in a
cell-type-dependent manner. In our system, the differential response of male and female
cells to E2 may be due to differences in the expression levels of estrogen receptors in
response to E2. We therefore determined the levels of ERα and
ERβ mRNA. Figures 4i and j show that
ERα levels did not statistically change in both male and female cells
following E2 treatment. We also observed similar levels of ERβ expression
(not shown).
Estradiol treatment of male mice induces apoptosis in kidney during nephrotoxic
nephritis (NTN)
To confirm the relevance of our results, we determined the effect of E2 treatment on
apoptosis and necrosis in the kidneys of male and female mice during NTN. To treat mice
with estrogens, E2 pellets were implanted s.c. as described in ‘Materials and
Methods'. Kidneys were collected 30 h following NTS injection.
Paraffin-embedded sections were stained for active caspase-3 as a measure of apoptosis
and Poly (ADP-Ribose) Polymers (PARs) as a measure of PARP-1 activation and as a
mediator of necrosis. Figure 5a shows that NTS induced
apoptosis only in males treated with E2, and therefore supports our in vitro
observations. Figure 5a also shows that E2 inhibits
caspase-3 activation in females, which is in agreement with our in vitro
results showing that E2 inhibits both apoptosis and necrosis in female cells (Figures 4a–f). In line with the results in Figures 4g and h, PARP-1 activation in males is inhibited by E2,
whereas E2 had no effect on PARP-1 activation in females (Figure
5b). However, real-time PCR data showed that treatment of male mice with E2
significantly increased ERα expression (Figure
5c), whereas ERα expression in female mice was unaffected by
additional E2 treatment (Figure 5d). The apparent
differences in the ability of E2 to increase ERα between our in
vitro and in vivo data could be due to a prolonged E2 treatment in
vivo compared to a short-term treatment of cells in vitro.
Figure 5
E2 treatment induces caspase-3 activation following NTN in male but not in female mice.
To determine the role of E2 in the induction of cells death, we treated male or female
mice with estrogens by implanting E2 pellets s.c. NTS (6 ml/kg) was injected
5 days following pellet implantation, and the kidneys were collected after 30 h.
Paraffin-embedded kidney sections were stained for active caspase-3 as a measure of
apoptosis (a) or PAR as a measure of PARP-1 activation (b). Fluorescence
intensities of red channel were measured using ImageJ software (lower panels).
Fluorescence intensities of the secondary controls were subtracted from the stained
sections. An average of 7–10 fields was calculated for each mouse. Data are
mean±S.E.M., representative of six mice. The data show that E2 treatment of male
mice results in increased apoptotic cell death and inhibition of necrosis following
induction of nephritis. ERα mRNA expression in the renal tissue from male
(c) or female (d) mice was determined by quantitative PCR and normalized
to mRNA levels in an untreated mouse of same sex. The results show that E2 treatment of
males resulted in the upregulation of ERα in the kidney. The data are
representative of six mice. *P<0.05, **P<0.005,
***P<0.0005
Discussion
Our data suggest that cell death is influenced by the biological sex. One of the
mechanisms is through the activation of PARP-1. Necrosis in males is PARP-1-dependent,
with absence or inhibition of PARP-1 switching the inflammatory cell death program to an
anti-inflammatory apoptotic death program. In females, PARP-1 activation is independent of
necrosis induction; however, estrogens have a survival role in these cells. The ability of
estrogen to rescue female cells from death is independent of estrogen receptor expression,
as ERα expression in male and female cells was similar. We propose that
male cells are programmed to undergo necrosis, whereas female cells preferentially undergo
apoptosis and that estrogens may have an important role in this sex-biased cell death.The switch between necrosis and apoptosis upon PARP-1 inhibition was first reported in
peroxinitrite-induced cell death in thymocytes.[36] A similar switch has been reported in alkylating DNA damage-induced
death in humantumor cell lines.[37, 38] Liu et al.[37] suggested that ATP levels were a determining factor for the fate
of the cell. Our data are consistent with the literature; however, in the present study we
report a sex bias in the induction of necrosis by PARP-1. Specifically, we show that
absence of PARP-1 induced apoptosis only in male cells.Males and females respond differently to stress. Our data suggest that proclivity of male
and female cells to different forms of cell death may contribute to the different
responses of males and females to stress. We suggest PARP-1 as one of the mediators.
PARP-1 is activated in both males and females (Figures 1 and
5b); however, the inhibition of PARP-1 in an inflammatory
setting is protective only in males.[22] Whether
PARP-1 activation in females is a consequence of massive inflammatory stimulus and whether
females have evolutionarily developed pathways of inducing necrosis independently of
PARP-1 remains to be determined. In this study we show that E2 inhibits PARP-1 activation
stimulated by H2O2 only in male cells. We hypothesize that due to
higher levels of E2, females may have a different pathway for inducing necrosis
independent of PARP-1 activation; however, the necrotic cell death pathway utilized by
female cells is still unclear. PARP-1 activity has been shown to regulate basal and
ligand-induced androgen receptor (AR) functions.[39] Although signaling through AR has been shown to induce
apoptosis,[40, 41,
42] the exact mechanism of how AR regulates death
is not clear. Moreover, the relevance of PARP-1 interaction with AR to regulate cell death
is not yet known. Therefore, we cannot rule out a role for AR signaling in the sex bias we
observe with PARP-1-induced cell death.Extensive research has been focused on elucidating the role of sex hormones in sexual
dimorphism observed in several diseases. The protection of females from inflammatory
responses has been shown in several disease models. Exercise-induced muscle inflammatory
response is less severe in women than in men,[43]
female rodents have improved hepatocellular function following trauma, and also improved
survival in sepsis. However, chromosomal differences between males and females may also
contribute to differences in their responses to stress. Male and female kidneys are known
to be developmentally different. Females have more glomeruli per gram of kidney weight and
lower renal plasma flow.[44] Furthermore, a role
for sex-chromosome component has been established in autoimmune diseases such as
experimental autoimmune encephalomyelitis and lupus.[29] The mosaic expression pattern of X chromosome genes in female is
proposed to be protective.[45] Females have two
copies of X chromosome, and therefore, two alleles for genes on X chromosome. The
X-chromosome inactivation is in a mosaic pattern, resulting in different cells having
different alleles actively transcribed. A mutation in one allele produces less-prominent
phenotypic changes due to expression of the normal allele in another cell. However, in
males the same mutation is not compensated for by the second allele, which may be the
reason for increased severity of diseases caused by a mutation in single X-linked gene,
such as Fragile X Syndrome and hemophilia.Several cell death pathways such as the pathways regulated by mitogen-activated protein
kinases (JNK, ERK and p38) are activated by ischemia/reperfusion and trauma
hemorrhage, and are believed to be regulated by sex hormones.[46, 47, 48] Estrogens are also protective in cardiomyocyte injury. Patten et
al.[49] showed that estrogen-mediated
activation of the phospho-inositide-3 kinase (PI3K)-Akt pathway reduces cardiomyocyte
apoptosis in vivo and in vitro. In this study we propose that the
differences in the responses of males and females to stress may be due to inherent
differences in susceptibility to undergo inflammatory necrosis. We further show that the
responses of males and females to estrogen are different. It is likely that females have
evolutionarily developed reduced sensitivity to estrogens and have developed alternative
pathways to undergo necrotic cell death. The understanding of these pathways in females
requires further studies. In line with this hypothesis, it would be interesting to
determine the susceptibility to necrosis of cells from men with Klinefelter's
syndrome (KS). KS (47, XXY) is the most common sex-chromosome disorder in
man.[50] Analysis of responses of cells from
KS men to various death stimuli may explain whether a gene-dose effect is responsible for
different susceptibilities of male and females to necrosis. Interestingly and pertinent to
our observation, KS men with SLE have a milder disease and especially a milder form of
nephritis, possibly due to a lesser activation of the necrotic pathway.[51]Owing to differences in the responses to stimuli and mortality rates between males and
females, there is a need for novel biomarkers and gender-based therapeutic approaches.
Necrotic cell death is recognized as programmed and therefore potentially controllable.
Our data suggest that males and females are prone to different types of cell death and
this may explain how sex contributes to the frequency and severity of diseases such as
lupus glomerulonephritis. Understanding the molecular pathways regulating tissue damage in
males versus females will lead to tailored treatments for each gender.
Materials and Methods
Mice
129sv, 129 PARP-1−/− and C57/BL6 (B6) mice were obtained from
Jackson Laboratories (Bar Harbor, ME, USA). B6. RIP-3−/− mice were a
kind gift from Dr. Dixit (Genentech) and were obtained from Fox Chase Cancer Center.
Breeding colonies were maintained at Temple University in accordance with the guidelines
of the University Laboratory Animal Resource Office of Temple University. All
experimental procedures were conducted according to the guidelines of the Institutional
Animal Care and Use Committee. NTN was induced, as described previously, by using a
single injection of NTS.[22] For estrogen
treatment, 17β-estradiol (E2) pellets (Innovative Research of America,
Sarasota, FL, USA) were implanted s.c. NTS (6 mg/ml[22]) was injected 5 days later and kidneys were harvested
30 h following NTS injection. Paraffin-embedded kidney sections from lupus-prone
(NZWxBXSB)F1 mice were generously provided by Dr. A Davidson (Feinstein Institute, New
York, NY, USA). In this model male mice develop a more severe renal disease than
females.[25] To accelerate lupus disease in
females and obtain a comparable renal disease, (NZWxBXSB)F1 female mice were injected
with an adenovirus expressing Interferon Alpha (AdvIFNα) at 8 weeks of
age. Kidneys were harvested at 22 weeks of age, as previously published.[25] The (NZWxBXSB)F1 males were 18 weeks old. All mice
had proteinuria at the time of tissue harvest.
BMDM cultures
BMDM were generated as described previously[52]
with the following modifications. Briefly, bone marrow cells were cultured in phenol
red-free RPMI 1640 supplemented with 5% FBS, recombinant mouseMCSF
(10 ng/ml) and L929 conditioned medium (15%). Non-adherent cells were
collected after 24 h and cultured in Corning Ultra Low six-well plates (Corning
Inc., Tewksbury, MA, USA) for 7–9 days. The medium was supplemented once on day 4
and every day after day 7. To deplete estrogens in the cultures,
charcoal-dextran-treated fetal bovine serum was used for culturing BMDM and L929
cells.
Ex vivo cell death
Paraffin-embedded kidney sections were dewaxed with xylenes and rehydrated with
decreasing concentrations of alcohol. Active caspase-3 was stained using a rabbit
polyclonal antibody (BD Biosciences, San Jose, CA, USA) following heat-induced antigen
retrieval. Poly (ADP-Ribose) polymers were stained, as described
previously,[22] using polyclonal anti-PAR
antibody (Enzo Life Sciences Inc., Farmingdale, NY, USA). Images were acquired on Zeiss
Meta laser scanning confocal microscope (Carl Zeiss Microscopy, LLC, Tornwood, NY, USA)
equipped with Zen software. The data were analyzed by ImageJ software (http://rsbweb.nih.gov/ij/). The
channels were separated (blue and green or blue and red). The mean fluorescence
intensity (MFI) of each field was calculated for either red or green channel. The MFI
for the sections with secondary antibody only were used for background calculations and
were subtracted from the MFI values obtained from the sections stained with primary
antibody. A minimum of 5–7 fields for each section/mouse were analyzed.
In vitro cell death
Cell death was induced by stimulating cells with H2O2. Following
a 2-h stimulation, cells were harvested, stained with FITC-conjugated Annexin V and
propidium iodide or 7AAD, and acquired on BD FACS Canto immediately. Apoptotic cells
were defined as Annexin V single-positive, necrotic as Propidium
Iodide/7AAD-positive and live cells as Annexin V-negative Propidium
Iodide/7AAD-negative.[53, 54] Cells were stained for intracellular caspase-3 using
PE-conjugated active caspase-3 antibody (BD Biosciences) according to the
manufacturer's instructions. For E2 treatment, cells were incubated with different
concentrations of E2 for 3 h prior to stimulation with
H2O2. For caspase-3 inhibition cells were pre-treated with
Z-DEVD-FMK (50 μM) for 30 min followed by further
2-h stimulation with H2O2. For microscopy, cells were labeled with
DNA dye Hoechst 33342 during the 2-h stimulation with H2O2.
Following stimulation, cells were fixed with 4% paraformaldehyde, and visualized
with Zeiss Meta laser scanning confocal microscope. Cells were counted from 8–10
fields per condition (minimum of 100 cells) and the percentage of apoptotic and necrotic
cells was calculated.
Western blotting
BMDMs were stimulated with H2O2 for 2 h. Protein
concentration in whole-cell lysates was determined by bicinchoninic acid (BCA) kit
(Pierce Thermo Scientific, Rockford, IL, USA). Equal proteins were separated on
12% sodium dodecyl sulfate–polyacrylamide gel (SDS-PAGE) and transferred to
nitrocellulose membrane. Anti-active caspase-3 antibody (Cell Signaling Technology,
Inc., Danvers, MA, USA) was used to detect active caspase-3, and blots were developed
using an ECL system Pierce Thermo Scientific. As a loading control, blots were re-probed
with anti-β-actin antibody (Sigma-Aldrich, St. Louis, MO, USA). Band
intensities were calculated using gel analyzer (ImageJ). The supernatants were collected
and spun at 1500 r.p.m. for 10 min to remove cell remnants. Equal volumes
of supernatants were concentrated using Amicon ultra concentrators (EMD Millipore,
Billerica, MA, USA), separated using SDS-PAGE and transferred to nitrocellulose
membrane. Anti-active caspase-3 antibody (Cell Signaling Technology, Inc.) was used to
detect active caspase-3, and blots were developed using an ECL system (Pierce Thermo
Scientific). As a positive control we induced apoptosis in Jurkat cells by stimulating
with 4 μM camptothecin for 3 h. Whole-cell lysates
of treated and untreated Jurkat cells were used for western blots as positive and
negative controls for active caspase-3.
In vitro PARP-1 activity
PARP-1 activity in BMDMs was determined using a colorimetric assay, as described
previously.[55] Briefly, cells were seeded
in a 96-well plate and stimulated with 500 μM
H2O2. Following stimulation, the medium was replaced with PARP-1
reaction buffer (56 mM HEPES, 28 mM KCl,
28 mM NaCl, 2 mM MgCl2, pH 8.0, 0.01%
digitonin and 10 μM biotinylated NAD+).
The cells were fixed with pre-chilled 95% ethanol (10 min at −20C),
and endogenous peroxidase was blocked by 0.5% H2O2 in
methanol for 15 min. Cells were washed once with 1 × PBS and blocked with
1% BSA/PBS. After 30 min, BSA solution was aspirated and
streptavidin–peroxidase (Jackson Immunoresearch Laboratories, West Grove, PA, USA)
was added. Color was developed with TMB substrate (R&D Systems Inc., Minneapolis,
MN, USA). The optical density was measured with a microplate spectrophotometer. For E2
treatments, cells were incubated with different concentration of E2 for 3 h prior
to stimulation.
Real-time PCR
Total RNA was isolated using Qiagen RNeasy kit (Qiagen, Valencia, CA, USA). RNA
(1 μg) was reverse-transcribed using Applied Biosystems
high-capacity reverse-transcription kit (Applied Biosystems, Foster City, CA, USA).
Estrogen Receptor α (Esr1) and Estrogen Receptor β
(Esr2) gene expression, normalized to GAPDH, was detected by real-time PCR
using QuantiTect primer assays (Qiagen) and Eppendorf Realplex thermal cycler. The mRNA
transcripts were quantified by standard curve method. RNA isolated from the uterus of a
female mouse was used to generate the standard curve.
Statistical analysis
ANOVA and t-tests were performed using GraphPad Prism 4.0c software for Mac
(GraphPad Software, Inc., La Jolla, CA, USA). Differences among groups were determined
using the Tukey–Kramer post hoc test. Statistical significance was
defined as P <0.05.
Authors: J A Girón-González; F J Moral; J Elvira; D García-Gil; F Guerrero; I Gavilán; L Escobar Journal: Eur J Endocrinol Date: 2000-07 Impact factor: 6.664
Authors: Edina Bakondi; Péter Bai; Eva Szabó E; János Hunyadi; Pál Gergely; Csaba Szabó; László Virág Journal: J Histochem Cytochem Date: 2002-01 Impact factor: 2.479
Authors: L Tentori; A Balduzzi; I Portarena; L Levati; P Vernole; B Gold; E Bonmassar; G Graziani Journal: Cell Death Differ Date: 2001-08 Impact factor: 15.828
Authors: Xuesong Liu; Xu Luo; Yan Shi; Gui-Dong Zhu; Thomas Penning; Vincent L Giranda; Yan Luo Journal: Cancer Biol Ther Date: 2008-03-19 Impact factor: 4.742
Authors: Meera Ramanujam; Philip Kahn; Weiqing Huang; Haiou Tao; Michael P Madaio; Stephen M Factor; Anne Davidson Journal: Arthritis Rheum Date: 2009-04
Authors: Deborah L Smith-Bouvier; Anagha A Divekar; Manda Sasidhar; Sienmi Du; Seema K Tiwari-Woodruff; Jennifer K King; Arthur P Arnold; Ram Raj Singh; Rhonda R Voskuhl Journal: J Exp Med Date: 2008-04-28 Impact factor: 14.307
Authors: Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo Journal: Br J Pharmacol Date: 2017-03-26 Impact factor: 8.739
Authors: Silvia Maifrede; Esteban Martinez; Margaret Nieborowska-Skorska; Daniela Di Marcantonio; Michael Hulse; Bac Viet Le; Huaqing Zhao; Katarzyna Piwocka; Italo Tempera; Stephen M Sykes; Tomasz Skorski Journal: Blood Adv Date: 2017-08-09
Authors: Ruslan Rafikov; Vineet Nair; Shripad Sinari; Harini Babu; Jennifer C Sullivan; Jason X-J Yuan; Ankit A Desai; Olga Rafikova Journal: Antioxid Redox Signal Date: 2019-03-20 Impact factor: 8.401
Authors: Kate Liu; Elizabeth Singer; Whitaker Cohn; Ewa D Micewicz; William H McBride; Julian P Whitelegge; Joseph A Loo Journal: Proteomics Clin Appl Date: 2019-09-04 Impact factor: 3.494